Processa pharmaceuticals to present at the world orphan drug congress usa, july 11-13, 2022

Hanover, md., july 12, 2022 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) ("processa" or the "company"), a clinical stage biopharmaceutical company developing drugs to improve the survival and/or quality of life for patients who have unmet medical conditions announced today that dr. david young, it's chief executive officer, will present “thinking regulatory first - considerations for the effective development of rare disease therapies” at the world orphan drug congress usa 2022 conference on wednesday, july 13, 2022 at 3:25 pm edt.
PCSA Ratings Summary
PCSA Quant Ranking